Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02019732 · ClinicalTrials.gov registry record
Study to Assess the Burden of Mild Outcomes (Physician Office Visits) Due to Influenza in the United States
A clinical trial, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- 1
- Enrollment target
NCT02019732: Completed study, sponsored by GlaxoSmithKline.
NCT02019732 is a clinical trial that has completed, run by GlaxoSmithKline. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02019732 has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- 1 participants
- Enrollment target
Study Summary
This is a database study to quantify the burden of multiple mild outcomes (i.e., those that result in visits to a physician's office) attributable to influenza in the United States, stratified by age group, geographic region and influenza subtype for selected influenza seasons.
Primary Outcome
\- All the events contained within "potentially influenza-attributable" office visits. - Weekly proportion of circulating influenza A and B strains determined for each season.
Interventions
- OTHER Data collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2013-01 |
| Est. Completion | 2013-06 |
What the finished NCT02019732 record still lists
NCT02019732 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 1 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Data collection is the first listed.
NCT02019732 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02019732 about?
NCT02019732 is a clinical study titled "Study to Assess the Burden of Mild Outcomes (Physician Office Visits) Due to Influenza in the United States". This is a database study to quantify the burden of multiple mild outcomes (i.e., those that result in visits to a physician's office) attributable to influenza in the United States, stratified by age group, geographic region and influenza subtype for selected influenza seasons.
What is the current status of trial NCT02019732?
This trial is currently completed. The enrollment target is 1 participants. The study started on 2013-01. Estimated completion is 2013-06.
What interventions are being tested in trial NCT02019732?
The interventions under investigation include: Data collection (OTHER).
Who is sponsoring clinical trial NCT02019732?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia